Home > Cashflow Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Cash Flow from Operating Activities

    Back to Cashflow Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Cash Flow from Operating Activities ₹3,266 Cr₹2,368 Cr₹1,803 Cr₹2,005 Cr₹1,393 Cr

What is the latest Cash Flow from Operating Activities ratio of TORRENT PHARMACEUTICALS ?

The latest Cash Flow from Operating Activities ratio of TORRENT PHARMACEUTICALS is ₹3,266 Cr based on Mar2024 Consolidated results.
Year Cash Flow from Operating Activities
Mar2024₹3,266 Cr
Mar2023₹2,368 Cr
Mar2022₹1,803 Cr
Mar2021₹2,005 Cr
Mar2020₹1,393 Cr

How is Cash Flow from Operating Activities of TORRENT PHARMACEUTICALS Trending?

Years Cash Flow from Operating Activities % Change
Mar2024 ₹3,266 Cr
37.92
Mar2023 ₹2,368 Cr
31.34
Mar2022 ₹1,803 Cr
-10.09
Mar2021 ₹2,005 Cr
43.97
Mar2020 ₹1,393 Cr -

Compare Cash Flow from Operating Activities of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹108,462.3 Cr -3.3% -5.7% 28.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,132.0 Cr 2.2% -5.8% 22.9% Stock Analytics
DIVIS LABORATORIES ₹149,254.0 Cr 4.1% -7% 52% Stock Analytics
CIPLA ₹116,123.0 Cr 1.3% -4.8% 9.5% Stock Analytics
DR REDDYS LABORATORIES ₹100,573.0 Cr 2.2% -10.9% -0.6% Stock Analytics
ZYDUS LIFESCIENCES ₹97,966.9 Cr 7% -0.2% 27.5% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

-3.3%

-5.7%

28.7%

SENSEX

2.8%

-3.1%

9%


You may also like the below Video Courses